Erdosteine | Carbocysteine | NAC | Placebo | |
---|---|---|---|---|
Total number of subjects | 354 | 557 | 553 | 1151 |
Frequency (%) of all AEs | 1.32 (+++) | 2.26 (+++) | 18.26 (++++) | 8.43 (+++) |
Frequency (%) of specific AEs: | ||||
respiratory tract infection | ND | 0.56 (+++) | 10.85 (++++) | 4.26 (+++) |
gastrointestinal disorders | 0.44 (++) | 1.13 (+++) | 4.16 (+++) | 4.26 (+++) |
pruritus | ND | ND | 1.08 (+++) | 2.69 (+++) |
cerebrovascular disorders | 0.44 (++) | ND | 0.90 (++) | 0.09 (+) |
dizziness | ND | ND | 0.72 (++) | 0.09 (+) |
musculoskeletal disorders | ND | 0.28 (++) | 0.54 (++) | 0.78 (++) |
hepatobiliary disorders | 0.44 (++) | ND | ND | ND |
malaise | ND | 0.28 (++) | ND | 0.09 (+) |
insomnia | ND | ND | ND | 0.26 (++) |
increased cough | ND | ND | ND | 0.17 (++) |